Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH
Marica Cariello, Elena Piccinin, Antonio Moschetta
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 11, Iss. 5, pp. 1519-1539
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
Tobias Puengel, Hanyang Liu, Adrien Guillot, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2668-2668
Open Access | Times Cited: 74
Polysaccharides from Phellinus linteus attenuate type 2 diabetes mellitus in rats via modulation of gut microbiota and bile acid metabolism
Tingting Liu, Min Zhao, Yumeng Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 130062-130062
Closed Access | Times Cited: 18
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Arshi Khanam, Paul Saleeb, Shyam Kottilil
Cells (2021) Vol. 10, Iss. 5, pp. 1097-1097
Open Access | Times Cited: 85
HIF: a master regulator of nutrient availability and metabolic cross‐talk in the tumor microenvironment
Rindert Missiaen, Nicholas P. Lesner, M. Celeste Simon
The EMBO Journal (2023) Vol. 42, Iss. 6
Open Access | Times Cited: 35
Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review
Haider Ghazanfar, Nismat Javed, Abeer Qasim, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1214-1214
Open Access | Times Cited: 15
Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
Sandra Torres, Paula Segalés, Carmen García‐Ruiz, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1475-1475
Open Access | Times Cited: 36
Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis
Junjie Zhang, Yan Shen, Xiaohong Chen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 22
Polysaccharides from Platycodon grandiflorus attenuates high-fat diet induced obesity in mice through targeting gut microbiota
Weixin Ke, Kate J. Flay, Xiaoning Huang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115318-115318
Open Access | Times Cited: 19
From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention
Benedetta Maria Motta, Mario Masarone, Pietro Torre, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5458-5458
Open Access | Times Cited: 19
FXR and NASH: an avenue for tissue-specific regulation
Zakiyah Henry, Vik Meadows, Grace L. Guo
Hepatology Communications (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 18
Dapagliflozin ameliorates hepatic steatosis via suppressing LXRα-mediated synthesis of lipids and bile acids
Zijie Jin, Ruotong Yin, Yan Yuan, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116167-116167
Closed Access | Times Cited: 8
Targeting nuclear receptors for NASH/MASH: From bench to bedside
Rohit A. Sinha
Liver Research (2024) Vol. 8, Iss. 1, pp. 34-45
Open Access | Times Cited: 7
Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease
Jiashu Pan, Wenjun Zhou, Ruohui Xu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113127-113127
Open Access | Times Cited: 28
Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism
Weinan Zhou, Sayeepriyadarshini Anakk
Molecular and Cellular Endocrinology (2022) Vol. 549, pp. 111616-111616
Open Access | Times Cited: 25
The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease
Zhenhua Yang, Awang Danzeng, Qiumeng Liu, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 113-126
Open Access | Times Cited: 16
Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
Hye-Jin Kim, Chaewon Park, Tae Hyun Kim
Cells (2023) Vol. 12, Iss. 9, pp. 1292-1292
Open Access | Times Cited: 15
Guar gum improves growth performance, intestinal microbiota homeostasis, and hepatic lipid metabolism in juvenile largemouth bass (Micropterus salmoides) fed high-fat diets
Shiyang Gao, Weijun Chen, Yuanyuan Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 235, pp. 123807-123807
Closed Access | Times Cited: 14
Osteogenesis of bone marrow mesenchymal stem cell in hyperglycemia
Meng Luo, Zhihe Zhao, Jianru Yi
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
Integrate mechanistic evidence from new approach methodologies (NAMs) into a read-across assessment to characterise trends in shared mode of action
Sylvia E. Escher, Alejandro Aguayo‐Orozco, Emilio Benfenati, et al.
Toxicology in Vitro (2021) Vol. 79, pp. 105269-105269
Open Access | Times Cited: 28
Dysregulation of S-adenosylmethionine Metabolism in Nonalcoholic Steatohepatitis Leads to Polyamine Flux and Oxidative Stress
Connor Quinn, Mario C. Rico, Carmen Merali, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 1986-1986
Open Access | Times Cited: 20
Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal inflammatory, and barrier function by activating the farnesoid X receptor
Kaijia Tang, Danli Kong, Yuan Peng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
High-Carbohydrate Diet Consumption Poses a More Severe Liver Cholesterol Deposition than a High-Fat and High-Calorie Diet in Mice
Linyu Zhang, Xin Li, Xiangyan Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14700-14700
Open Access | Times Cited: 13
Metabolism in tumor-associated macrophages
Jie Li, Gina M. DeNicola, Brian Ruffell
International review of cell and molecular biology (2022), pp. 65-100
Open Access | Times Cited: 17
Adipose tissue–specific ablation of Ces1d causes metabolic dysregulation in mice
Gang� Li, Xin Li, Li Yang, et al.
Life Science Alliance (2022) Vol. 5, Iss. 8, pp. e202101209-e202101209
Open Access | Times Cited: 17
Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials
Joel Yeh Siang Chen, Damien Chua, Carissa Odelia Lim, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 158-158
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top